SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
27-Sep-24 4:26 PM View: | Bioage Labs, Inc. (BIOA) | 27-Sep-24 | Conversion | 1,310,590 | -- | -- | 100% 0 to 1.31M | |
27-Sep-24 4:26 PM View: | Bioage Labs, Inc. (BIOA) | 27-Sep-24 | Purchase | 400,000 | $18.00 | $7,200,000.00 | 31% 1.31M to 1.71M | |
16-Sep-24 8:57 PM View: | Zenas Biopharma, Inc. (ZBIO) | 16-Sep-24 | Conversion | 2,061,930 | -- | -- | (119%) (-1.73M) to 334.53K | |
16-Sep-24 8:57 PM View: | Zenas Biopharma, Inc. (ZBIO) | 16-Sep-24 | Market Purchase | 440,000 | $17.00 | $7,480,000.00 | 132% 334.53K to 774.53K | |
06-Aug-24 6:45 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 02-Aug-24 | Grant | 3,731 | -- | -- | 18% 20.95K to 24.68K | |
15-Aug-23 5:45 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 14-Aug-23 | Sale | 1,241 | $138.16 | $171,455.00 | (6%) 22.19K to 20.95K | |
15-Aug-23 5:45 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 11-Aug-23 | Grant | 3,075 | -- | -- | 16% 19.11K to 22.19K | |
08-Feb-23 7:32 PM View: | Vera Therapeutics, Inc. (VERA) | 06-Feb-23 | Private Purchase | 1,714,280 | $7.00 | $12,000,000.00 | 50% 3.43M to 5.14M | |
25-Nov-22 9:33 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 22-Nov-22 | Market Sale | 4,974 | $149.48 | $743,513.00 | (19%) 26.09K to 21.11K | 2% |
25-Nov-22 9:33 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 22-Nov-22 | Market Sale | 2,000 | $152.88 | $305,751.00 | (9%) 21.11K to 19.11K | 4% |
09-Aug-22 6:12 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 08-Aug-22 | Sale | 1,089 | $152.33 | $165,883.00 | (4%) 27.18K to 26.09K | |
09-Aug-22 6:12 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 05-Aug-22 | Grant | 2,561 | -- | -- | 10% 24.61K to 27.18K | |
05-Apr-22 7:22 AM View: | Vera Therapeutics, Inc. (VERA) | 10-Feb-22 | Private Purchase | 333,333 | $15.00 | $5,000,000.00 | 11% 3.1M to 3.43M | |
20-Aug-21 7:12 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 18-Aug-21 | Grant | 2,000 | $137.75 | $275,500.00 | 9% 22.61K to 24.61K | (5%) |
02-Aug-21 6:10 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 29-Jul-21 | Grant | 2,246 | -- | -- | 11% 20.37K to 22.61K | |
18-May-21 8:14 PM View: | Vera Therapeutics, Inc. (VERA) | 18-May-21 | Conversion Duplicate | 2,187,500 | -- | -- | 100% 0 to 2.19M | |
18-May-21 8:14 PM View: | Vera Therapeutics, Inc. (VERA) | 18-May-21 | Private Purchase | 909,090 | $11.00 | $9,999,990.00 | 42% 2.19M to 3.1M | |
13-Nov-20 4:56 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 12-Nov-20 | Market Sale (Planned) | 9,929 | $146.71 | $1,456,740.00 | (33%) 30.3K to 20.37K | (7%) |
04-Nov-20 7:26 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 02-Nov-20 | Option Exercise | 9,929 | -- | -- | 49% 20.37K to 30.3K | |
14-Oct-20 4:15 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 13-Oct-20 | Disposition | 7,840 | $34.50 | $270,480.00 | (100%) 7.84K to 0 | |
14-Oct-20 4:15 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 10-Oct-20 | Disposition (change in control) | 70,561 | $34.50 | $2,434,350.00 | (43%) 162.26K to 91.7K | |
14-Oct-20 4:15 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 10-Oct-20 | Disposition (change in control) | 91,697 | $34.50 | $3,163,550.00 | (100%) 91.7K to 0 | |
23-Sep-20 9:35 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 21-Sep-20 | Acquisition (other) | 91,697 | -- | -- | 1% 6.19M to 6.28M | |
23-Sep-20 9:35 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 21-Sep-20 | Disposition (other) | 6,113,130 | -- | -- | (97%) 6.28M to 170.1K | |
10-Aug-20 4:42 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 06-Aug-20 | Grant | 2,705 | -- | -- | 15% 17.66K to 20.37K | |
29-May-20 7:13 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 27-May-20 | Sale | 7,840 | -- | -- | < 1% 6.18M to 6.19M | |
19-Mar-20 5:03 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 18-Mar-20 | Private Purchase | 16,213 | $11.06 | $179,345.00 | < 1% 6.17M to 6.18M | |
19-Mar-20 5:03 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 17-Mar-20 | Private Purchase | 100,000 | $11.40 | $1,139,650.00 | 2% 6.06M to 6.16M | |
19-Mar-20 5:03 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 17-Mar-20 | Private Purchase | 8,787 | $11.50 | $101,050.00 | < 1% 6.16M to 6.17M | |
14-Jan-20 4:16 PM View: | Aptinyx Inc. (APTX) | 10-Jan-20 | Market Purchase | 95,000 | $3.00 | $285,000.00 | 3% 3.19M to 3.29M | 21% |
14-Jan-20 4:16 PM View: | Aptinyx Inc. (APTX) | 10-Jan-20 | Market Purchase | 166,667 | $3.00 | $500,001.00 | 5% 3.29M to 3.45M | 21% |
19-Sep-19 4:05 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 17-Sep-19 | Grant | 12,500 | $22.34 | $279,216.00 | < 1% 6.05M to 6.06M | |
12-Aug-19 5:50 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 09-Aug-19 | Market Sale | 726 | $135.65 | $98,481.10 | (4%) 18.39K to 17.66K | (16%) |
12-Aug-19 5:50 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 08-Aug-19 | Grant | 1,920 | -- | -- | 12% 16.47K to 18.39K | |
28-May-19 9:18 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 23-May-19 | Grant | 6,442 | -- | -- | < 1% 6.04M to 6.05M | |
07-Sep-18 4:30 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 06-Sep-18 | Option Exercise | 10,130 | $139.10 | $1,409,090.00 | 62% 16.47K to 26.6K | 2% |
07-Sep-18 4:30 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 06-Sep-18 | Market Option Sale (Planned) | 10,130 | $168.76 | $1,709,560.00 | (38%) 26.6K to 16.47K | 7% |
13-Aug-18 6:13 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 10-Aug-18 | Market Sale | 1,365 | $175.13 | $239,057.00 | (8%) 17.83K to 16.47K | 10% |
13-Aug-18 6:13 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 09-Aug-18 | Grant | 1,495 | -- | -- | 9% 16.34K to 17.83K | |
26-Jun-18 4:49 PM View: | Aptinyx Inc. (APTX) | 25-Jun-18 | Conversion Duplicate | 3,040,080 | -- | -- | 100% 0 to 3.04M | |
26-Jun-18 4:49 PM View: | Aptinyx Inc. (APTX) | 25-Jun-18 | Purchase Duplicate | 150,000 | $16.00 | $2,400,000.00 | 5% 3.04M to 3.19M | |
24-May-18 5:09 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 23-May-18 | Grant | 3,750 | -- | -- | < 1% 6.04M to 6.04M | |
26-Feb-18 4:22 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 22-Feb-18 | Market Purchase | 15,593 | $32.00 | $498,976.00 | < 1% 6.02M to 6.04M | (24%) |
13-Dec-17 5:52 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 11-Dec-17 | Option Exercise | 9,000 | $64.29 | $578,655.00 | 55% 16.34K to 25.34K | |
13-Dec-17 5:52 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 11-Dec-17 | Market Option Sale (Planned) | 9,000 | $139.73 | $1,257,580.00 | (36%) 25.34K to 16.34K | (13%) |
21-Nov-17 5:27 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 17-Nov-17 | Market Sale (Planned) | 352 | $133.19 | $46,882.90 | (< 1%) 221.72K to 221.37K | (18%) |
28-Aug-17 6:10 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 25-Aug-17 | Market Sale (Planned) | 351 | $148.40 | $52,088.40 | (< 1%) 222.07K to 221.72K | (6%) |
14-Aug-17 5:17 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 11-Aug-17 | Market Sale | 662 | $142.37 | $94,247.60 | (< 1%) 222.73K to 222.07K | (10%) |
14-Aug-17 5:17 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 10-Aug-17 | Grant | 1,365 | -- | -- | < 1% 221.37K to 222.73K | |
20-Mar-17 4:36 PM View: | Corcept Therapeutics Inc. (CORT) | 16-Mar-17 | Market Sale | 269,955 | $9.94 | $2,683,240.00 | (4%) 6.38M to 6.11M | (182%) |